CA Patent

CA2871171A1 — Tramadol for treating depression

Assigned to E Therapeutics PLC · Expires 2013-11-07 · 13y expired

What this patent protects

There is described a sub-analgesic amount of tramadol, or a salt thereof, in the treatment, alleviation or prevention of depression in a patient wherein the sub- analgesic amount is from about 60 to 80mg, of tramadol or a salt thereof.

USPTO Abstract

There is described a sub-analgesic amount of tramadol, or a salt thereof, in the treatment, alleviation or prevention of depression in a patient wherein the sub- analgesic amount is from about 60 to 80mg, of tramadol or a salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number: CA2871171A1
Jurisdiction: CA
Classification: —
Expires: 2013-11-07
Drug substance claim: No
Drug product claim: No
Assignee: E Therapeutics PLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.